Ke-Qin Hu1, Calvin Q Pan, Diane Goodwin. 1. Division of GI/Hepatology, University of California, Irvine, 101, The City Drive, Building 56, Rt. 81, Rm. 231, Orange, CA 92868, USA. kqhu@uci.edu
Abstract
BACKGROUND: Routine screening for hepatitis B virus (HBV) infection can identify individuals who need vaccination or treatment, as vaccination can prevent HBV infection. Although the overall prevalence of HBV infection in the United States is low (<1%), it is high (~10%) in Asian Americans. However, HBV screening rates in this population have been reported to be low. AIMS: This article systemically reviews the reported prevalence of HBV infection, the rate of HBV screening and access to HBV care, barriers for HBV screening and care, and a possible approach for improving HBV screening in Asian Americans. METHODS: Articles published from 1999 to 2011 on HBV screening and disparity in Asian Americans were identified by searching electronic databases (PubMed and Cochrane Library), and reviewed. RESULTS: Published studies, including a recent report from the Institute of Medicine of the National Academies, revealed HBV screening rates are low in Asian Americans. This review addresses the need for HBV screening in Asian Americans. Barriers to HBV screening are related to patients, providers, and/or the healthcare system. Screening programs that incorporate culturally sensitive interventions and include educational outreach, vaccination, and a link to healthcare services improve rates of HBV screening and vaccination in this at-risk community. CONCLUSIONS: A strategy that integrates efforts from the healthcare profession, federal agencies, and the community will be needed to improve HBV screening and access to HBV care for Asian Americans.
BACKGROUND: Routine screening for hepatitis B virus (HBV) infection can identify individuals who need vaccination or treatment, as vaccination can prevent HBV infection. Although the overall prevalence of HBV infection in the United States is low (<1%), it is high (~10%) in Asian Americans. However, HBV screening rates in this population have been reported to be low. AIMS: This article systemically reviews the reported prevalence of HBV infection, the rate of HBV screening and access to HBV care, barriers for HBV screening and care, and a possible approach for improving HBV screening in Asian Americans. METHODS: Articles published from 1999 to 2011 on HBV screening and disparity in Asian Americans were identified by searching electronic databases (PubMed and Cochrane Library), and reviewed. RESULTS: Published studies, including a recent report from the Institute of Medicine of the National Academies, revealed HBV screening rates are low in Asian Americans. This review addresses the need for HBV screening in Asian Americans. Barriers to HBV screening are related to patients, providers, and/or the healthcare system. Screening programs that incorporate culturally sensitive interventions and include educational outreach, vaccination, and a link to healthcare services improve rates of HBV screening and vaccination in this at-risk community. CONCLUSIONS: A strategy that integrates efforts from the healthcare profession, federal agencies, and the community will be needed to improve HBV screening and access to HBV care for Asian Americans.
Authors: Scott P Grytdal; Youlian Liao; Roxana Chen; Cheza C Garvin; Dorcas Grigg-Saito; Marjorie Kagawa-Singer; Sidney Liang; Stephen J McPhee; Tung T Nguyen; Jacqueline H Tran; Kathleen M Gallagher Journal: J Community Health Date: 2009-06
Authors: Leslie D Hsu; William DeJong; Renee Hsia; Michael Chang; Marvin Ryou; Ellen Yeh Journal: Am J Public Health Date: 2003-08 Impact factor: 9.308
Authors: Victoria M Taylor; Yutaka Yasui; Nancy Burke; Tung Nguyen; Anthony Chen; Elizabeth Acorda; John H Choe; J Carey Jackson Journal: Cancer Detect Prev Date: 2004
Authors: Eugene R Schiff; Ching-Lung Lai; Stefanos Hadziyannis; Peter Neuhaus; Norah Terrault; Massimo Colombo; Hans L Tillmann; Didier Samuel; Stefan Zeuzem; Leslie Lilly; Maria Rendina; Jean-Pierre Villeneuve; Nicole Lama; Craig James; Michael S Wulfsohn; Hamid Namini; Christopher Westland; Shelly Xiong; Gavin S Choy; Sally Van Doren; John Fry; Carol L Brosgart Journal: Hepatology Date: 2003-12 Impact factor: 17.425
Authors: Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11 Impact factor: 4.254
Authors: Benjamin J Lee; Sheila K Wang; Chunkit So; Brandon G Chiu; Wesley Y Wang; Radhika Polisetty; Ana Quiñones-Boex; Hong Liu Journal: Am J Pharm Educ Date: 2015-11-25 Impact factor: 2.047
Authors: Cynthia Jorgensen; Sherry Chen; C Amanda Carnes; Joan Block; Daniel Chen; Jeffrey Caballero; Kate Moraras; Chari Cohen Journal: Public Health Rep Date: 2016 May-Jun Impact factor: 2.792
Authors: Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili Journal: Dig Dis Sci Date: 2013-09-20 Impact factor: 3.199
Authors: Andrew A Li; Donghee Kim; Won Kim; Pratima Dibba; Katherine Wong; George Cholankeril; Ira M Jacobson; Zobair M Younossi; Aijaz Ahmed Journal: J Viral Hepat Date: 2018-09-11 Impact factor: 3.728
Authors: Matthew S Chang; Ruth Tuomala; Anna E Rutherford; Muthoka L Mutinga; Karin L Andersson; Blaire E Burman; Robert S Brown; Emily Oken; Chinweike Ukomadu Journal: Am J Obstet Gynecol Date: 2014-09-30 Impact factor: 8.661